Spyre Therapeutics, Inc.
SYRE
$103.63
$1.781.75%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.15B | 741.47M | 756.53M | 486.20M | 526.58M |
| Total Receivables | 8.80M | 7.60M | 3.00M | 6.60M | 3.50M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 18.86M | 14.89M | 18.25M | 11.81M | 8.75M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.17B | 763.95M | 777.78M | 504.60M | 538.83M |
|
|
|||||
| Total Current Assets | 1.17B | 763.95M | 777.78M | 504.60M | 538.83M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.17B | 763.95M | 777.78M | 504.60M | 538.83M |
|
|
|||||
| Total Accounts Payable | 5.72M | 5.69M | 8.90M | 7.46M | 3.71M |
| Total Accrued Expenses | 26.18M | 29.16M | 26.77M | 23.83M | 19.42M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 31.40M | 50.31M | 23.01M | 14.99M | 59.93M |
| Total Other Current Liabilities | 31.40M | 50.31M | 23.01M | 14.99M | 59.93M |
| Total Current Liabilities | 63.30M | 85.16M | 58.69M | 46.27M | 83.06M |
|
|
|||||
| Total Current Liabilities | 63.30M | 85.16M | 58.69M | 46.27M | 83.06M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 8.56M | 7.98M | 3.86M | 3.23M | -- |
| Total Liabilities | 71.86M | 93.14M | 62.55M | 49.50M | 83.06M |
|
|
|||||
| Common Stock & APIC | 2.19B | 1.71B | 1.69B | 1.36B | 1.35B |
| Retained Earnings | -1.23B | -1.20B | -1.13B | -1.07B | -1.05B |
| Treasury Stock & Other | -2.40M | -767.00K | 869.00K | 791.00K | 454.00K |
| Total Common Equity | 954.72M | 514.99M | 559.42M | 299.28M | 299.95M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 146.43M | 155.82M | 155.82M | 155.82M | 155.82M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 146.43M | 155.82M | 155.82M | 155.82M | 155.82M |
|
|
|||||
| Total Common Equity | 954.72M | 514.99M | 559.42M | 299.28M | 299.95M |
| Total Preferred Equity | 146.43M | 155.82M | 155.82M | 155.82M | 155.82M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.10B | 670.81M | 715.24M | 455.10M | 455.77M |
|
|
|||||